Completed NA INTERVENTIONAL 2-arm NCT04176835

Oxytocin and Social Decision Making in Schizophrenia

Neurobiological Effects of Oxytocin on Social Decision Making in Schizophrenia: A Pharmacological MRI Study

Sponsor: National Institute of Mental Health and Neuro Sciences, India

Interventions Oxytocin nasal spray Placebo

Updated 5 times since 2019 Last updated: Sep 27, 2022 Started: Apr 30, 2016 Primary completion: Sep 30, 2019 Completion: Sep 30, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Schizophrenia, this trial is completed. The trial is conducted by National Institute of Mental Health and Neuro Sciences, India and has accumulated 5 data snapshots since 2016. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Oct 2022 — Jul 2024 [monthly]

Completed NA
Jan 2021 — Oct 2022 [monthly]

Completed NA
Dec 2019 — Jan 2021 [monthly]

Completed NA

First recorded

Apr 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute of Mental Health and Neuro Sciences, India

Data source: National Institute of Mental Health and Neuro Sciences, India

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.